MADALYN GUELKER: Open Payments
NPI 1225781925 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 84 payments from 14 companies in 2025. Trend: 2023 $1,466 · 2024 $1,056 · 2025 $1,583
Food & beverage: $1,495Education: $88
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $368 |
| Janssen Biotech, Inc. | 20 | $344 |
| GENZYME CORPORATION | 13 | $234 |
| Arcutis Biotherapeutics, Inc. | 5 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Incyte Corporation | 4 | $81 |
| UCB, Inc. | 3 | $76 |
| Amgen Inc. | 3 | $61 |
| LEO Pharma Inc. | 2 | $48 |
| Organon LLC | 3 | $46 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, Zoryve, OPZELURA, Bimzelx, OTEZLA, COSENTYX.
Industry payments across TX — which companies pay providers there.
